Teva Pharmaceutical Industries shares owned by Balyasny Asset Management
Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Balyasny Asset Management
from 13F filings
Historical chart of Balyasny Asset Management investment in Teva Pharmaceutical Industries
Tip: Access up to 7 years of quarterly data
All positions including Teva Pharmaceutical Industries held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Teva Pharmaceutical Industries by Balyasny Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $44M | 2.4M | 18.02 |
2024-06-30 | $61M | 3.7M | 16.25 |
2024-03-31 | $44M | 3.1M | 14.11 |
2023-09-30 | $5.7M | 560k | 10.20 |
2023-03-31 | $17M | 1.9M | 8.85 |
2022-12-31 | $16M | 1.8M | 9.12 |
2022-06-30 | $20M | 2.6M | 7.52 |
2022-03-31 | $8.5M | 904k | 9.39 |
2021-12-31 | $158k | 20k | 8.00 |
2019-03-31 | $25M | 1.6M | 15.68 |
2018-12-31 | $12M | 782k | 15.42 |
2018-09-30 | $35M | 1.6M | 21.54 |
2018-06-30 | $40M | 1.7M | 24.32 |
2018-03-31 | $27M | 1.6M | 17.09 |
2017-12-31 | $24M | 1.3M | 18.95 |
2017-09-30 | $33M | 1.8M | 17.60 |
2017-06-30 | $6.6M | 200k | 33.22 |
2016-12-31 | $17M | 456k | 36.25 |
2016-09-30 | $6.2M | 135k | 46.01 |
2016-06-30 | $20M | 400k | 50.23 |
2016-03-31 | $33M | 611k | 53.51 |
2015-12-31 | $223M | 3.4M | 65.64 |
2015-09-30 | $72M | 1.3M | 56.46 |
2015-06-30 | $79M | 1.3M | 59.10 |
2015-03-31 | $4.0M | 64k | 62.30 |
2014-12-31 | $40M | 697k | 57.51 |
2014-09-30 | $9.4M | 175k | 53.75 |
2014-06-30 | $21M | 391k | 52.42 |
2014-03-31 | $15M | 285k | 52.84 |
2013-12-31 | $5.6M | 140k | 40.08 |
2013-09-30 | $23M | 617k | 37.78 |
2013-06-30 | $32M | 803k | 39.20 |
2013-03-31 | $15M | 389k | 39.68 |
2012-12-31 | $3.9M | 104k | 37.34 |
2012-06-30 | $4.4M | 113k | 39.45 |
2011-12-31 | $2.5M | 61k | 40.36 |
2011-03-31 | $7.8M | 155k | 50.17 |
Top funds holding Teva Pharmaceutical Industries
View all funds holding Teva Pharmaceutical Industries